Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099515 · ClinicalTrials.gov registry record · Phase 2
Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 97
- Enrollment target
NCT00099515 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 97 participants.
The verdict
NCT00099515, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 97 participants
- Enrollment target
Study Summary
The purpose of this study is to compare intensive and standard training for human insulin inhalation powder in patients with type 2 diabetes.
Interventions
- DRUG LY041001 (HIIP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00099515
The ClinicalTrials.gov registry entry for NCT00099515 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LY041001 (HIIP) is the first listed.
NCT00099515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00099515 about?
NCT00099515 is a clinical study titled "Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)". The purpose of this study is to compare intensive and standard training for human insulin inhalation powder in patients with type 2 diabetes.
What is the current status of trial NCT00099515?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 97 participants. The study started on 2004-11. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00099515?
The interventions under investigation include: LY041001 (HIIP) (DRUG).
Who is sponsoring clinical trial NCT00099515?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.